To confirm that miR-146b controls tumor growth through the p110β-dependent PI3K/AKT pathway, we treated miR-146b−/− macrophages ex vivo with inhibitors of p110β, PI3K and AKT prior to mixing the macrophages with tumor cells and implanting them in mice. This evidence concerns the gene AKT1 and neoplasm.